search
Back to results

VRAP-Heart - Virtual Reality Assisted Patient Empowerment for Interventions in Structural Heart Disease (VRAP-Heart)

Primary Purpose

Severe Aortic Valve Stenosis

Status
Recruiting
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Virtual Reality assisted information
Sponsored by
Heinrich-Heine University, Duesseldorf
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Severe Aortic Valve Stenosis

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • High-grade aortic valve stenosis
  • Indication for elective transfemoral transcatheter aortic valve implantation under analgesia (TAVI)
  • Existing heart center decision
  • Age ≥ 18 years
  • Signed informed consent form

Exclusion Criteria:

  • Surgery planned under general anesthesia
  • Language barrier
  • Severe hearing or vision impairment
  • Advanced dementia syndrome
  • Known seizure disorder (epilepsy)
  • Positive pregnancy test on inclusion and/or pregnancy is present
  • Court ordered placement in an institution
  • Any psychosocial condition that makes compliance with the protocol unlikely

Sites / Locations

  • Universitätsklinikum Düsseldorf, Klinik für Kardiologie, Pneumologie & AngiologieRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Intervention Arm

Control Arm

Arm Description

Patients in the intervention arm receive on the day before the implantation of the artificial aortic valve, a virtual reality assisted information. On the day of the implantation the patients are informed about the process via virtual reality assisted information.

Patients in the control arm receive no virtual reality assisted information.

Outcomes

Primary Outcome Measures

Length of hospital stay in days
Primary endpoint is the mean hospital stay in each group in days.

Secondary Outcome Measures

Mental state on the day before the procedure as assessed by visual analog scale
Anxiety and psychological stress are common before elective procedures such as TAVI. Both are considered triggers and amplifiers of delirium. Patients are asked to quantify their anxiety before the procedure using a visual analog scale ranging from 1 to 10.
Mental state on the day before the procedure as assessed by State-Trait-Anxiety-Inventory questionnaire
Anxiety and psychological stress are common before elective procedures such as TAVI. Both are considered triggers and amplifiers of delirium. Patients are asked to quantify their anxiety before the procedure using State-Trait-Anxiety-Inventory with minimum outcome 10 and maximum outcome 80. Lesser outcome means more anxiety.
Mental state on the day before the procedure as assessed by Hospital Anxiety and Depression Scale German Version questionnaire
Anxiety and psychological stress are common before elective procedures such as TAVI. Both are considered triggers and amplifiers of delirium. Patients are asked to quantify their anxiety before the procedure using Hospital Anxiety and Depression Scale German Version questionnaire. Anxiety scale in the questionnaire has values from 0 to 21 and Depression scale has values from 0 to 21. Lesser values denote less anxiety or depression.
Anxiety during the procedure as assessed by visual analog scale
Anxiety and psychological stress are common during elective procedures such as TAVI. Both are considered triggers and amplifiers of delirium. Patients are asked to quantify their anxiety before the procedure using a visual analog scale ranging from 1 to 10.
Anxiety during the procedure as assessed by State-Trait-Anxiety-Inventory questionnaire
Anxiety and psychological stress are common during elective procedures such as TAVI. Both are considered triggers and amplifiers of delirium. Patients are asked to quantify their anxiety before the procedure using State-Trait-Anxiety-Inventory with minimum outcome 10 and maximum outcome 80. Lesser outcome means more anxiety.
Pain during the procedure
Pain can occur despite analgesia during an elective procedure such as TAVI. Pain is considered a trigger and amplifier of delirium. Patients are asked to quantify their pain on a visual analog scale during the procedure (time point: procedure performed but still in the hybrid operating room). Here, 0 corresponds to no pain and 10 to the maximum imaginable pain.
Anxiety/stress before, during, and after surgery (measured as serum cortisol)
Anxiety and psychological stress are common before and during elective procedures such as TAVI. Both are considered triggers and amplifiers of delirium. Patients will have routine blood samples taken before, during, and after the procedure. From these, the parameter cortisol in serum is additionally determined optionally in the context of this study. Serum cortisol is an established parameter to quantify anxiety and stress, especially intraindividually.
Anxiety / stress before, during and after the procedure (amylase and cortisol in saliva).
Patients will have saliva samples taken before, during and after the procedure. From these, the parameters cortisol and alpha-amylase are additionally determined on an optional basis within the scope of this study. Both parameters are considered established to quantify anxiety and stress especially intraindividually.
Knowledge test after informed consent
In order to test to what extent the addition of a combination of different learning modalities (acoustic, visual, written, haptic) implemented in virtual reality to the medico-legal informed consent is superior to the standard informed consent, a survey is conducted after the informed consent.
Major bleeding and minor bleeding during hospitalization.
Bleeding is a typical complication after cardio-vascular interventional procedures. Unawareness, disorientation, falls, and delirium favor the occurrence of bleeding. After hospital discharge, the occurrence of bleeding is recorded according to Valve Academic Research Consortium-2 consensus document (VARC), which is based on the bleeding academic research consortium (BARC) classification.
Survival / rehospitalization at 6 and 12 months
After 6 and 12 months patients are contacted and information is gathered about survival of the patients and possible rehospitalization events.
Maximum length of hospital stay, in days
In addition to the mean hospital stay in days, a maximum hospital stay is also calculated.

Full Information

First Posted
September 12, 2022
Last Updated
December 22, 2022
Sponsor
Heinrich-Heine University, Duesseldorf
Collaborators
Edwards Lifesciences
search

1. Study Identification

Unique Protocol Identification Number
NCT05552352
Brief Title
VRAP-Heart - Virtual Reality Assisted Patient Empowerment for Interventions in Structural Heart Disease
Acronym
VRAP-Heart
Official Title
VRAP-Heart - Virtual Reality Assisted Patient Empowerment for Interventions in Structural Heart Disease - A Randomized-Controlled Multicenter Study
Study Type
Interventional

2. Study Status

Record Verification Date
December 2022
Overall Recruitment Status
Recruiting
Study Start Date
October 5, 2022 (Actual)
Primary Completion Date
June 30, 2023 (Anticipated)
Study Completion Date
May 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Heinrich-Heine University, Duesseldorf
Collaborators
Edwards Lifesciences

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This prospective, randomized-controlled multicenter study investigates whether virtual reality-assisted patient education in patients undergoing transfemoral transcatheter aortic valve implantation (TAVI) can improve patient understanding and simulative orientation, thereby reducing postinterventional complications, resulting in significantly shorter length of stay.
Detailed Description
This prospective, randomized-controlled multicenter study investigates whether VR-assisted patient education in patients undergoing transfemoral transcatheter aortic valve implantation (TAVI) can improve patient understanding and simulative orientation, thereby reducing postinterventional complications, resulting in significantly shorter length of stay. Disorientation, anxiety, and pain can lead to the development of delirium and, through complications, to prolonged hospital stays during elective procedures. Virtual reality can combine different learning modalities (auditory, visual, written, haptic) and improve patient understanding of the procedure through educational interventions. More detailed knowledge of the environment, the players, the procedure, and safety aspects will reduce anxiety and stress before and during the procedure and reduce complications during post-interventional care. As a result, length of stay should be reduced.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Severe Aortic Valve Stenosis

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Two-armed, randomized with controlled parallel groups.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
300 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention Arm
Arm Type
Experimental
Arm Description
Patients in the intervention arm receive on the day before the implantation of the artificial aortic valve, a virtual reality assisted information. On the day of the implantation the patients are informed about the process via virtual reality assisted information.
Arm Title
Control Arm
Arm Type
No Intervention
Arm Description
Patients in the control arm receive no virtual reality assisted information.
Intervention Type
Other
Intervention Name(s)
Virtual Reality assisted information
Intervention Description
Patients in the intervention group receive a VR instructional application in the patient's room the day before TAVI implantation and in the operational suite during TAVI implantation the next day. In this application, the patient is guided through different VR parts that repeat the indication, the procedure, the localities and the post-interventional phase of the implantation with the corresponding safety instructions.
Primary Outcome Measure Information:
Title
Length of hospital stay in days
Description
Primary endpoint is the mean hospital stay in each group in days.
Time Frame
from start of hospitalizations until hospital leave up until day 360
Secondary Outcome Measure Information:
Title
Mental state on the day before the procedure as assessed by visual analog scale
Description
Anxiety and psychological stress are common before elective procedures such as TAVI. Both are considered triggers and amplifiers of delirium. Patients are asked to quantify their anxiety before the procedure using a visual analog scale ranging from 1 to 10.
Time Frame
1 day before procedure
Title
Mental state on the day before the procedure as assessed by State-Trait-Anxiety-Inventory questionnaire
Description
Anxiety and psychological stress are common before elective procedures such as TAVI. Both are considered triggers and amplifiers of delirium. Patients are asked to quantify their anxiety before the procedure using State-Trait-Anxiety-Inventory with minimum outcome 10 and maximum outcome 80. Lesser outcome means more anxiety.
Time Frame
1 day before procedure
Title
Mental state on the day before the procedure as assessed by Hospital Anxiety and Depression Scale German Version questionnaire
Description
Anxiety and psychological stress are common before elective procedures such as TAVI. Both are considered triggers and amplifiers of delirium. Patients are asked to quantify their anxiety before the procedure using Hospital Anxiety and Depression Scale German Version questionnaire. Anxiety scale in the questionnaire has values from 0 to 21 and Depression scale has values from 0 to 21. Lesser values denote less anxiety or depression.
Time Frame
1 day before procedure
Title
Anxiety during the procedure as assessed by visual analog scale
Description
Anxiety and psychological stress are common during elective procedures such as TAVI. Both are considered triggers and amplifiers of delirium. Patients are asked to quantify their anxiety before the procedure using a visual analog scale ranging from 1 to 10.
Time Frame
during procedure
Title
Anxiety during the procedure as assessed by State-Trait-Anxiety-Inventory questionnaire
Description
Anxiety and psychological stress are common during elective procedures such as TAVI. Both are considered triggers and amplifiers of delirium. Patients are asked to quantify their anxiety before the procedure using State-Trait-Anxiety-Inventory with minimum outcome 10 and maximum outcome 80. Lesser outcome means more anxiety.
Time Frame
during procedure
Title
Pain during the procedure
Description
Pain can occur despite analgesia during an elective procedure such as TAVI. Pain is considered a trigger and amplifier of delirium. Patients are asked to quantify their pain on a visual analog scale during the procedure (time point: procedure performed but still in the hybrid operating room). Here, 0 corresponds to no pain and 10 to the maximum imaginable pain.
Time Frame
during procedure
Title
Anxiety/stress before, during, and after surgery (measured as serum cortisol)
Description
Anxiety and psychological stress are common before and during elective procedures such as TAVI. Both are considered triggers and amplifiers of delirium. Patients will have routine blood samples taken before, during, and after the procedure. From these, the parameter cortisol in serum is additionally determined optionally in the context of this study. Serum cortisol is an established parameter to quantify anxiety and stress, especially intraindividually.
Time Frame
on the 1 day before, during and on day 1-3 after procedure
Title
Anxiety / stress before, during and after the procedure (amylase and cortisol in saliva).
Description
Patients will have saliva samples taken before, during and after the procedure. From these, the parameters cortisol and alpha-amylase are additionally determined on an optional basis within the scope of this study. Both parameters are considered established to quantify anxiety and stress especially intraindividually.
Time Frame
on the 1 day before, during and on day 1-3 after procedure
Title
Knowledge test after informed consent
Description
In order to test to what extent the addition of a combination of different learning modalities (acoustic, visual, written, haptic) implemented in virtual reality to the medico-legal informed consent is superior to the standard informed consent, a survey is conducted after the informed consent.
Time Frame
1 day before procedure after informed consent
Title
Major bleeding and minor bleeding during hospitalization.
Description
Bleeding is a typical complication after cardio-vascular interventional procedures. Unawareness, disorientation, falls, and delirium favor the occurrence of bleeding. After hospital discharge, the occurrence of bleeding is recorded according to Valve Academic Research Consortium-2 consensus document (VARC), which is based on the bleeding academic research consortium (BARC) classification.
Time Frame
at hospital leave up to 360 days after procedure
Title
Survival / rehospitalization at 6 and 12 months
Description
After 6 and 12 months patients are contacted and information is gathered about survival of the patients and possible rehospitalization events.
Time Frame
after 6 and 12 months after hospital leave
Title
Maximum length of hospital stay, in days
Description
In addition to the mean hospital stay in days, a maximum hospital stay is also calculated.
Time Frame
at hospital leave up to 360 days after procedure

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: High-grade aortic valve stenosis Indication for elective transfemoral transcatheter aortic valve implantation under analgesia (TAVI) Existing heart center decision Age ≥ 18 years Signed informed consent form Exclusion Criteria: Surgery planned under general anesthesia Language barrier Severe hearing or vision impairment Advanced dementia syndrome Known seizure disorder (epilepsy) Positive pregnancy test on inclusion and/or pregnancy is present Court ordered placement in an institution Any psychosocial condition that makes compliance with the protocol unlikely
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Christian Jung, Prof MD PhD
Phone
+49 211 81
Ext
18567
Email
christian.jung@med.uni-duesseldorf.de
First Name & Middle Initial & Last Name or Official Title & Degree
Raphael Bruno, MD
Phone
+49 211 81
Ext
18800
Email
raphael.bruno@med.uni-duesseldorf.de
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christian Jung, Prof MD PhD
Organizational Affiliation
Heinrich-Heine University, Duesseldorf
Official's Role
Principal Investigator
Facility Information:
Facility Name
Universitätsklinikum Düsseldorf, Klinik für Kardiologie, Pneumologie & Angiologie
City
Düsseldorf
State/Province
NRW
ZIP/Postal Code
40225
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Christian Jung, Prof. MD PhD
Phone
+4921181
Ext
18567
Email
christian.jung@med.uni-duesseldorf.de
First Name & Middle Initial & Last Name & Degree
Raphael Bruno, MD
Phone
+4921181
Ext
18800
Email
raphael.bruno@med.uni-duesseldorf.de

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

VRAP-Heart - Virtual Reality Assisted Patient Empowerment for Interventions in Structural Heart Disease

We'll reach out to this number within 24 hrs